ConductScience.org, home

Paper35779484

The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma.

Tassone P and 8 others. Oral Oncol, 2022. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma. Papers, record 35779484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35779484

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma.
PubMed
Journal
Oral Oncol
PubMed
Year
2022
PubMed
Publication types
Letter
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2025-07-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tassone PPatrick
2Caruso CCarla
3White MMeghan
4Tavares Dos Santos HHarim
5Galloway TTabitha
6Dooley LLaura
7Zitsch R 3rdRobert
8Lester Layfield JJ
9Baker OOlga

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Head and Neck NeoplasmsMajor topic
Mouth NeoplasmsMajor topic
Fibroblasts
Humans
Matrix Metalloproteinase 2
Neoplasm Invasiveness
Prognosis
Squamous Cell Carcinoma of Head and Neck
Tumor Microenvironment
Vimentin

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42929829Cancer-Associated Fibroblasts in Perineural Invasion: Biological Roles and Therapeutic Strategies.Cells2026https://conductscience.org/library/papers/42929829PubMed
42365482Stromal Regulation of Tumor Perineural Invasion: A Multicellular and Neuro-Ecological Perspective.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42365482PubMed
42100436Perineural invasion in solid tumors: biological foundations and the emerging integration of machine learning and artificial intelligence.Front Oncol2026https://conductscience.org/library/papers/42100436PubMed
41938710Understanding nerve-tumor interactions: From basic biology to therapeutic innovation.Genes Dis2026https://conductscience.org/library/papers/41938710PubMed
41089673Single-cell and bulk RNA-sequencing reveal PRRX2-driven cancer-associated fibroblast-mediated perineural invasion for predicting the immunotherapy outcome in colorectal cancer.Front Cell Dev Biol2025https://conductscience.org/library/papers/41089673PubMed
40014866A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence.Cancer Res Commun2025https://conductscience.org/library/papers/40014866PubMed
39119085Hallmarks of perineural invasion in pancreatic ductal adenocarcinoma: new biological dimensions.Front Oncol2024https://conductscience.org/library/papers/39119085PubMed
37887547Unraveling the Mysteries of Perineural Invasion in Benign and Malignant Conditions.Curr Oncol2023https://conductscience.org/library/papers/37887547PubMed
37781863Overexpression of hsa_circ_0001861 inhibits pulmonary fibrosis through targeting miR-296-5p/BCL-2 binding component 3 axis.Eur J Histochem2023https://conductscience.org/library/papers/37781863PubMed
37736748Oral squamous cell carcinomas: state of the field and emerging directions.Int J Oral Sci2023https://conductscience.org/library/papers/37736748PubMed
37610689Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance.Cell Oncol (Dordr)2024https://conductscience.org/library/papers/37610689PubMed
36900158Important Cells and Factors from Tumor Microenvironment Participated in Perineural Invasion.Cancers (Basel)2023https://conductscience.org/library/papers/36900158PubMed
36677584Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity.Molecules2023https://conductscience.org/library/papers/36677584PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
VIM7431PubTator's text mininghttps://conductscience.org/library/genes/7431NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35779484

GET https://conductscience.org/api/papers/v1/35779484/authors